| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, Chair, Scientific Advisory Brd | Director
1 company
Wang Xiaodong is a Director, Chair, Scientific Advisory Brd at BeOne Medicines Ltd.. Recent SEC Form 4 filings include 0 buys and 79 sells.
Estimated insider holdings value: $1452.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sell | 2,007 | $265.50 | $532,867.36 | -45.4% | +26.6% | - | |
| Jun 10, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE | 41,760 | $262.82 | $10,975,315.61 | -37.8% | +31.5% | - | |
| May 13, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE | 41,760 | $223.50 | $9,333,272.13 | -49.8% | +28.9% | - | |
| Apr 14, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE | 41,760 | $242.66 | $10,133,595.25 | -16.3% | +3.9% | +27.6% | |
| Mar 18, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE | 41,760 | $261.28 | $10,911,252.24 | -24.3% | +1.2% | +8.0% | |
| Mar 4, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sell | 8,146 | $254.58 | $2,073,826.31 | -25.9% | -4.4% | +16.2% | |
| Feb 4, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE | 41,760 | $225.69 | $9,424,955.38 | -28.4% | +14.0% | +57.9% | |
| Jan 7, 2025 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE | 59,710 | $176.10 | $10,515,123.84 | -48.1% | +26.0% | +90.7% | |
| Dec 10, 2024 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE | 41,760 | $186.90 | $7,805,105.81 | -25.0% | +29.4% | +72.1% | |
| Nov 26, 2024 | ONC Beone Medicines Ltd. | Director, Chair, Scientific Advisory Brd | Sale+OE | 48,351 | $190.08 | $9,190,569.92 | -15.6% | +34.6% | +77.3% |